Skip to content

Author

Dustin A Staloch

We have 4 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Safety, Efficacy, and Effectiveness of Pulsed Field Ablation with Farapulse™ to Treat Atrial Fibrillation: A Prospective Single-center Study

Pulsed field ablation (PFA) using the Farapulse™ system (Boston Scientific, Marlborough, MA, USA) is a novel, non-thermal ablation technology developed to treat atrial fibrillation (AF) with improved safety and procedural efficiency. We present prospective single-center data on the safety, efficacy, and effectiveness o...

Dean Sabayon, Deaa Abu Jazar, K. Alabdallah et al. · 0 citations
Open access Oct 2026

Timing of Catheter Ablation After Heart Failure Diagnosis for Atrial Fibrillation: A Propensity-Score-Matched Analysis.

BACKGROUND Catheter ablation improves outcomes in patients with atrial fibrillation (AF) and heart failure (HF). However, most of the evidence on the importance of ablation timing has been anchored to AF rather than HF onset, leaving the optimal interval between HF diagnosis and ablation incompletely defined. OBJECTI...

Ahmad Al-Abdouh, Omar Obeidat, Laith Alhuneafat et al. · 0 citations
Jul 2026

Secondary Atrial Fibrillation in Critically Ill Sepsis Patients: Evaluating the Role of Early Oral Anticoagulants in a Retrospective Multi-Center Study.

In sepsis-associated NOAF, early OAC initiation was associated with reduced short-term mortality and ischemic stroke without excess bleeding or thromboembolic risk and warrant cautious interpretation given the observational design.

A. Qadeer, Michele Fouad, Doaa Bayomi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.